Complement and the damaging effects of cardiopulmonary bypass.

Postoperative cardiac, pulmonary, renal and coagulation dysfunction, along with C3a levels, were studied prospectively in 116 consecutive patients undergoing open cardiac operations and 12 patients undergoing closed operations in the same time period. The level of C3a 3 hours after open operation was high (median value 882 ng X ml-1 plasma) and was related to the C3a level before cardiopulmonary bypass (CPB) (p = 0.03), the level at the end of CPB (p less than 0.0001), elapsed time of CPB (p = 0.07), and older age at operation (p less than 0.0001). It was inversely related to the cardiac output as reflected by the strength of the pedal pulses (p = 0.006). In contrast, C3a levels did not rise in patients undergoing closed operations. The probability of postoperative cardiac dysfunction after open operations (present in 27 of 116 patients) was predicted by C3a levels 3 hours after operation (p = 0.02), the CPB time (p = 0.02), and younger age (p less than 0.0001). The same risk factors pertained for postoperative pulmonary dysfunction (present in 41 of the 116 patients); renal dysfunction (present in 24 of the 116 patients) except that CPB time was not a risk factor here; abnormal bleeding (present in 21 of the 116 patients); and important overall morbidity (present in 26 of 116 patients). As regards important overall morbidity, the C3a level effect became evident at about 1,900 ng X ml-1 (a level reached by 9% of patients); the effect of increasing time of CPB became evident at about 90 minutes of CPB time; and the effect of young age became evident as age decreased from 10 to 4 years. This study demonstrates the damaging effects of CPB, relates them in part to complement activation by the foreign surfaces encountered by the blood, and supports the hypothesis that the mechanisms of the damaging effects include a whole-body inflammatory reaction.

[1]  J. Lazarus,et al.  Acute renal failure following cardiac operations. , 1980, The Journal of thoracic and cardiovascular surgery.

[2]  E. Blackstone,et al.  Determinants of early and late results of repair of atrioventricular septal (canal) defects. , 1982, The Journal of thoracic and cardiovascular surgery.

[3]  J. Kirklin,et al.  Cardiac Performance after Open Intracardiac Surgery , 1963, Circulation.

[4]  T. Hugli,et al.  Demonstration of specific C5a receptor on intact human polymorphonuclear leukocytes. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[5]  D. Hosmer,et al.  A computer program for stepwise logistic regression using maximum likelihood estimation. , 1978, Computer programs in biomedicine.

[6]  V. Willman,et al.  The effects of cardiopulmonary bypass with crystalloid and colloid hemodilution on myocardial extravascular water. , 1977, The Journal of thoracic and cardiovascular surgery.

[7]  E. Blackstone,et al.  Incremental risk factors in hospital mortality rate after repair of ventricular septal defect. , 1980, The Journal of thoracic and cardiovascular surgery.

[8]  E. Fonkalsrud,et al.  Denaturation of plasma proteins as a cause of morbidity and death after intracardiac operations. , 1961, Surgery.

[9]  A. Perel,et al.  Leukocytes Are Required for Increased Lung Microvascular Permeability after Microembolization in Sheep , 1981, Circulation research.

[10]  W. Roberts,et al.  Long-term morphologic and hemodynamic evaluation of the left ventricle after cardiopulmonary bypass. A comparison of normothermic anoxic arrest, coronary artery perfusion, and profound topical cardiac hypothermia. , 1975, The Journal of thoracic and cardiovascular surgery.

[11]  G. Buckberg,et al.  Depressed postoperative cardiac performance. Prevention by adequate myocardial protection during cardiopulmonary bypass. , 1975, The Journal of thoracic and cardiovascular surgery.

[12]  C. J. Lambert,et al.  The Treatment of Postperfusion Bleeding Using ε-Aminocaproic Acid, Cryoprecipitate, Fresh-Frozen Plasma, and Protamine Sulfate , 1979 .

[13]  N. Ratliff,et al.  Pulmonary injury secondary to extracorporeal circulation. An ultrastructural study. , 1973, The Journal of thoracic and cardiovascular surgery.

[14]  E. Blackstone,et al.  Intracardiac surgery in infants under age 3 months: incremental risk factors for hospital mortality. , 1981, The American journal of cardiology.

[15]  H. Gewurz,et al.  Complement activation by interaction of polyanions and polycations. I. Heparin-protamine induced consumption of complement. , 1975, Journal of immunology.

[16]  Karp Rb,et al.  Changes in serum complement and immunoglobulins following cardiopulmonary bypass. , 1972 .

[17]  A. Geha,et al.  Alveolar-arterial oxygen gradients after open intracardiac surgery. , 1966, The Journal of thoracic and cardiovascular surgery.

[18]  M. G. Lötter,et al.  Kinetics and sites of sequestration of indium 111-labeled human platelets during cardiopulmonary bypass. , 1981, The Journal of thoracic and cardiovascular surgery.

[19]  F. Bachmann,et al.  The hemostatic mechanism after open-heart surgery. II. Frequency of abnormal platelet functions during and after extracorporeal circulation. , 1975, The Journal of thoracic and cardiovascular surgery.

[20]  E. Blackstone,et al.  Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins. , 1981, The New England journal of medicine.

[21]  L. Aledort,et al.  Functional changes in platelets during extracorporeal circulation. , 1975, The Annals of thoracic surgery.

[22]  J. E. Woods,et al.  Effect of bypass surgery on coagulation-sensitive clotting factors. , 1967, Mayo Clinic proceedings.

[23]  Oscar Kempthore,et al.  Of what use are tests of significance and tests of hypothesis , 1976 .

[24]  A. Castañeda,et al.  Open-heart surgery during the first three months of life. , 1974, The Journal of thoracic and cardiovascular surgery.

[25]  C. Soriano,et al.  Cardiopulmonary bypass: Associated hemostatic abnormalities , 1979 .

[26]  G. Barnett,et al.  Etiology, incidence, and prognosis of renal failure following cardiac operations. Results of a prospective analysis of 500 consecutive patients. , 1976, The Journal of thoracic and cardiovascular surgery.

[27]  R S Kronenberg,et al.  Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis. , 1977, The New England journal of medicine.

[28]  H. Gewurz,et al.  INTERACTIONS OF C-REACTIVE PROTEIN WITH THE COMPLEMENT SYSTEM , 1974, The Journal of experimental medicine.

[29]  P. Clarkson,et al.  Repair of Ventricular Septal Defect in the First Two Years of Life Using Profound Hypothermia‐circulatory Arrest Techniques , 1976, Annals of surgery.

[30]  J. Eisele,et al.  COMPLEMENT AS A MEDIATOR OF INFLAMMATION , 1967, The Journal of experimental medicine.

[31]  D. Strong,et al.  Anaphylaxis to protamine sulfate mediated by a complement-dependent IgG antibody. , 1978, The Journal of allergy and clinical immunology.

[32]  L. Bonchek,et al.  Noncardiogenic pulmonary edema and peripheral vascular collapse following cardiopulmonary bypass: rare protamine reaction? , 1981, The Annals of thoracic surgery.

[33]  R. Whitlock,et al.  The effects of cardiopulmonary bypass upon pulmonary gas exchange. , 1978, The Journal of thoracic and cardiovascular surgery.

[34]  C. Mavroudis,et al.  Repair of congenital cardiac lesions during the first week of life. , 1982, Circulation.

[35]  Strother H. Walker,et al.  Estimation of the probability of an event as a function of several independent variables. , 1967, Biometrika.